TheEdgeResearch
Home / Stocks / RBCL

RBC Life Sciences, Inc. (RBCL)

OTC Consumer Defensive Household & Personal Products
$0.00 ▲ +0.00%
Market Cap
$1,549
Sector
Consumer Defensive
Industry
Household & Personal Products
Beta
4.13
52-Wk Range
0.0001-0.0007
CEO
David Price
Country
US
Currency
USD

RBC Life Sciences, Inc. operates in the Household & Personal Products industry of the Consumer Defensive sector, headquartered in Irving, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,549. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -2.9%. Its beta of 4.13 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
5.84
Gross margin
52.8%
Operating margin
-2.6%
Net margin
-2.9%
Return on equity
Debt / equity
0.00
Current ratio
2.28
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
89
IPO date
2000-01-03
Headquarters
Irving, TX, US
About RBC Life Sciences, Inc.

RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products. The company offers wellness products, weight loss, sports, and fitness products. RBC Life Sciences, Inc. is headquartered in Irving, Texas.

Comparable companies

RBC Life Sciences, Inc. is most often compared with the following Consumer Defensive names:

ANFIFCFPIFPWMKALRQMCHAPACVPCGRQKLSTUEMQURBF
More research on RBCL
RBCL technical analysis RBCL TheEdge Score Compare against peers
Open full interactive analysis & DCF →